Transcript This slideshow requires JavaScript.

Publishers of Quality Research
Bentham – Who we are?
• We are a major international Scientific, Technical &
Medical publisher of 131 online and print journals, 200
plus open access journals, and related print/online more
than 300 e-books, Bentham Science answers the
informational needs of the pharmaceutical, biomedical and
medical research community
• Leading publications include Current Gene Therapy,
Current Drug Metabolism, Current Molecular
Medicine and Current Medicinal Chemistry
• Bentham has experienced steady growth in subscriptions.
• Bentham Journals are endorsed by Nobel Laureates &
leading scientists.
Our products:
131 journal titles in Print & Online
• Journal Catalog
• New in 2014
Major Disciplines of Publications
Chemistry
Biotechnology
Genomics
Neuroscience
Proteomics
Bioinformatics
Patent Information
Engineering
Drug Design & Discovery
Immunology
Molecular Medicine
Oncology
Nanoscience
Drug Safety & Therapy
Pharmacology
Biochemistry
which includes:
• Review Articles : Comprehensive, timely in-depth reviews on a given
subject, written by leaders in the field.
• Original Papers : Cutting edge papers, published rapidly
For Academic and Pharmaceutical / Corporate Libraries
New in 2014:
Review Journals in the Fields of
• Applied Clinical Research, Clinical Trials and Regulatory
Affairs
• Clinical Anti-Inflammatory & Anti-Allergy Drugs
• Current Biochemical Engineering
• Clinical Cancer Drugs
• Clinical Cardiovascular Drugs
• Current Chromatography
• Current Environmental Engineering
• Clinical Immunology, Endocrine & Metabolic Drugs
• Current Green Chemistry
• Current Microwave Chemistry
• Clinical CNS Drugs
• Current Organocatalysis
New Journals in 2014:
Important to know:
•
1/3
Who are we: Bentham: a medium sized STM publisher of 130+ high
quality niche (review) journals in innovative upcoming areas such as
Physical Chemistry, Inorganic Chemistry and Patent information.
We publish the World's leading review journals in Molecular Medicine,
Drug Metabolism, Alzheimer, Cancer Drug Design, Drug Targets and
Medicinal Chemistry.
•
We publish: High Impact Factor, well indexed journals
•
Online access: Access via interface friendly platforms: Ingenta Connect,
•
Editors & authors:
Are selected worldwide, all key players in their fields.
2 titles (Current Pharmaceutical Design & Current Medicinal Chemistry)
in the top 28 Impact Factor ranking in Pharmacology and Pharmacy
6 Nobel Laureates endorse our journals!
CrossRef, Infotrieve, Ebsco, Swetwise, J-Gate and Bentham Direct. We
offer Counter compliant user statistics.
Important to know:
2/3
• Purchasing:
We offer subject specific journal
collections at good discounts to both library consortia
and institutional libraries
• 3-month FREE Online Trial:
extendable if
necessary. Our marketing department will assist with
promotion where required.
• Online back volumes: available at discount.
• Perpetual access
subscribed volumes.
is
available
for
paid
and
Important to know:
3/3
• Achievements:
• 38 Bentham journals have registered Impact
Factor ratings as per to journal citation report 2011
• 88 Subscription based journals received unofficial
impact factor rankings, according to recently
released Scopus (SCIMAGO) Citation Report 2011
• 19 Bentham Open Journals received unofficial
impact factor rankings, according to recently
released Scopus (SCIMAGO) Citation Report 2011
Nobel Laureates
Six Nobel laureates have endorsed a number
of Bentham Science journals
Nobel Laureates quote..
Nobel Laureates quote..
Editorial Board / Authors
• A dominant element in the success of
Bentham journals is the selection of key
editors worldwide.
• Majority of publishing authors and editorial
board members are from top international
universities and research institutions in North
America, Europe and Russia.
Leading Impact Factors
Rank
Journal Titles
Impact
Factor
1
Current Gene Therapy
5.318
2
Current Drug Metabolism
4.405
3
Current Molecular Medicine
4.197
4
Current Medicinal Chemistry
4.07
5
Current Cancer Drug Targets
4.00
6
Current Drug Targets
3.848
7
CNS & Neurological Disorders- Drug Targets
3.769
8
Current Topics in Medicinal Chemistry
3.702
9
Current Alzheimer Research
3.676
10
Current Pharmaceutical Design
3.311
ISI Journal Impact Factors 2012
Leading Impact Factors
Rank
Journal Titles
Impact
Factor
11
12
Current Organic Chemistry
3.039
Current Stem Cell Research & Therapy
2.963
13
Mini- Reviews in Medicinal Chemistry
2.865
14
Current Neurovascular Research
2.844
15
Current Vascular Pharmacology
2.821
16
Recent Patents on Anti-Cancer Drug Discov.
17
Current Pharmaceutical Biotechnology
2.69
Anti-Cancer Agents in Medicinal Chemistry
2.61
18
2.7
19
Current Genomics
2.475
20
Current Protein & Peptide Science
2.326
ISI Journal Impact Factors 2012
Out of 131 titles published
•
•
•
•
•
•
•
•
52 titles are indexed in MEDLINE
55 titles are indexed in Pub Med
49 titles are indexed by ISI
108 titles are indexed in Chemical Abstracts
96 titles are indexed in SCOPUS
73 titles are indexed by Google Scholar
117 titles are indexed in J gate
90 titles are indexed in Genomics Journal
Seek
Conditions:
• Standard prices apply for single site (unlimited users):
consortia and multi-site or multi-subscription packages
are negotiable.
• Cancellation of current subscriptions (print/online) is not
accepted unless specifically agreed upon during
negotiations, otherwise the consortium or multisite/subscription deal ceases immediately.
• Subscriptions are on calendar year basis and pro-rated
subscriptions are not allowed.
Innovations and news:
1/2
• Bentham has started an ambitious EBOOK program in 2009 and
aim to publish many interesting EBooks in various disciplines ,
currently we have more than 300 eBooks
• Bentham also publishes 200+ open access journals in various
disciplines
• Bentham is a member of CrossRef and all published articles
have doi's submitted. Several titles (CMC, CPD, CTMC and
CCHTS) offer referencing using the “Refine Resolution Service”
through Ingenta Connect.
• Bentham has developed Bentham Direct its own journal hosting
platform launched in August 2006: Full text pay per view access
and online trials are available.
• Bentham Direct is COUNTER-Compliant .
Innovations and news:
2/2
• Partnering with conferences globally
• Improving manuscript submission & tracking
• Advertising opportunities for print and online ads which provide
effective communication channels to reach core group of
researchers worldwide
• 38 Bentham journals have registered Impact Factor ratings as
per to journal citation report 2011
Upcoming Conferences in Early 2014
• 6th International Conference on Drug Discovery &
Therapy
February 10-12, 2014
Dubai, UAE
• 3rd Biotechnology World Congress
February 10-12, 2014
Dubai, UAE
• 247th American Chemical Society Spring National
Meeting & Exposition
March 16-20, 2014
Dallas, Texas
Upcoming Conferences in Early 2014
• 20th Annual Conference & Exhibition of SLA-AGC
March 25-27 , 2014
Doha, Qatar
• American Association for Cancer Research
April 5-9, 2014
San Diego, USA
• UKSG Annual Conference
April 14-16, 2014
Harrogate, UK
Conclusion
• Bentham Science Publications are an
immense value addition to your collection of
journals
Please visit www.benthamscience.com for more information.